Opinion

Kunal Jobanputra: One of the largest dataset reporting s-irAE and outcomes in NSCLC by Jarushka Naidoo

Kunal Jobanputra and Jarushka Naidoo

Dec 15, 2024, 19:50

Kunal Jobanputra: One of the largest dataset reporting s-irAE and outcomes in NSCLC by Jarushka Naidoo

Kunal Jobanputra, Medical Oncologist at Tata Memorial Hospital, shared on.X:

“One of the largest dataset reporting s-irAE and outcomes in advanced NSCLC by Jarushka Naidoo

8.6% of patients experienced s-irAEs, most often diarrhea (3.5%), pneumonitis (1.4%), and rash (1.3%).”

Management of severe immune-related adverse events and outcomes in patients with advanced non-small cell lung cancer receiving immune checkpoint inhibitors

Authors: Jarushka Naidoo, Douglas B Johnson, Charlotte Doran, Yuexi Wang, Yan Zhang, Trong Kim Le, Sari Hopson, Brian Dreyfus, Lincy S Lal, Charmy Vyas, Shay Goldstein, Zara Izadi

Kunal Jobanputra

Brian Dreyfus cancer Charlotte Doran Charmy Vyas Douglas B Johnson Jarushka Naidoo Kunal Jobanputra Lincy S Lal NSCLC OncoDaily Oncology Sari Hopson Shay Goldstein Trong Kim Le Yan Zhang Yuexi Wang Zara Izadi

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Bispecific Antibody M701 Offers a Novel Treatment Option for Malignant Ascites

Giuliana Rancic and Breast Cancer: How She Went Against, How She Survived, and More

Vincent Rajkumar: Paradigm changing AQUILA randomized trial in high risk smoldering myeloma

Special Coverage